Keywords: kyowa, considers, options, istradefylline, after, fda, approvable

Kyowa considers options on istradefylline after FDA "not approvable" letter

Article | 03 March 2008

Print This

Japanese drugmaker Kyowa Hakko Kogyo says that its wholly-owned US subsidiary has received a "not approvable" letter from the Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in